Aktie

Karuna Therapeutics

WKN
A2PM5N
Ticker
KRTX
ISIN
US48576A1007

Unternehmens­daten

Stammdaten zu Karuna Therapeutics

WKN
A2PM5N
ISIN
US48576A1007
Home-Symbol
KRTX
Symbol
Branche
Sektor
Unternehmen
Land

Marktdaten

Marktkapitalisierung
Anzahl Aktien
Streubesitz

Mitglieder & Anteilseigner

Anteilseigner

The Vanguard Group, Inc.Fidelity Management & Research Co. LLCT. Rowe Price Investment Management, Inc.T. Rowe Price Associates, Inc. (Investment Management)BlackRock Fund AdvisorsPuretech Health LLCSofinnova Investments, Inc.Wellington Management Co. LLPPentwater Capital Management LPPivotal Bioventure Partners Investment Advisor LLCGeneral Atlantic LLCSSgA Funds Management, Inc.Geode Capital Management LLCRock Springs Capital Management LPCapital Research & Management Co. (International Investors)UBS Securities LLCAllianceBernstein LPWoodline Partners LPBrown Advisory LLCNorges Bank Investment Management
  • The Vanguard Group, Inc. (8,32 %)
  • Fidelity Management & Research Co. LLC (7,51 %)
  • T. Rowe Price Investment Management, Inc. (7,10 %)
  • T. Rowe Price Associates, Inc. (Investment Management) (5,04 %)
  • BlackRock Fund Advisors (4,44 %)
  • Puretech Health LLC (4,01 %)
  • Sofinnova Investments, Inc. (3,62 %)
  • Wellington Management Co. LLP (2,97 %)
  • Pentwater Capital Management LP (2,79 %)
  • Pivotal Bioventure Partners Investment Advisor LLC (2,68 %)
  • General Atlantic LLC (2,59 %)
  • SSgA Funds Management, Inc. (2,55 %)
  • Geode Capital Management LLC (1,49 %)
  • Rock Springs Capital Management LP (1,35 %)
  • Capital Research & Management Co. (International Investors) (1,18 %)
  • UBS Securities LLC (1,10 %)
  • AllianceBernstein LP (0,99 %)
  • Woodline Partners LP (0,94 %)
  • Brown Advisory LLC (0,87 %)
  • Norges Bank Investment Management (0,86 %)

Kontakt